Name : DR6 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN2253348800
| Long name | DR6 Primary Polyclonal Antibody |
| Also known as | DR6 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | DR6 |
| Specificity | This is a highly specific antibody against DR6 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 140-170/655 |
| Subcellular location | Extracellular |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human DR6 |
| Gene ID number | 27242 |
| Swiss Prot | O75509 |
| Tested Applications | FCM |
| Recommended dilutions | FCM(1:20-100) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Can also promote apoptosis mediated by BAX and by the release of cytochrome c from the mitochondria into the cytoplasm, IL10, IL13 and IFNG by Th2 cells, IL5, IgM and IgM in response to antigens, May inhibit the activation of JNK in response to T-cell stimulation, N-APP binds TNFRSF21, Negatively regulates T-cell responses and the release of cytokines such as IL4, Negatively regulates oligodendrocyte survival, Negatively regulates the production of IgG, Plays a role in neuronal apoptosis, Plays a role in signaling cascades triggered by stimulation of T-cell receptors, Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP), and is required for both normal cell body death and axonal pruning, in the adaptive immune response and in the regulation of T-cell differentiation and proliferation, including apoptosis in response to amyloid peptides derived from APP, maturation and myelination, possibly via a pathway that involves the activation of NF-kappa-B, this triggers caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6), Promotes apoptosis |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | BM-018, CD358, Death receptor 6, TNFRSF21, Tumor necrosis factor receptor superfamily member 21, UNQ437/PRO868, DR6 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | DR6 |
| Short name | DR6 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | DR6 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 13469 |
| Gene | TNFRSF21 |
| Long gene name | TNF receptor superfamily member 21 |
| Synonyms gene name | member 21 , tumor necrosis factor receptor superfamily |
| Synonyms | DR6 CD358 |
| Synonyms name | death receptor 6 |
| Locus | 6p12, 3 |
| Discovery year | 2001-07-27 |
| GenBank acession | AF068868 |
| Entrez gene record | 27242 |
| Pubmed identfication | 9714541 |
| RefSeq identity | NM_014452 |
| Classification | CD molecules Tumor necrosis factor receptor superfamily |
| Havana BLAST/BLAT | OTTHUMG00000014796 |